Table 2.

Antibiotic susceptibility profiles of the 18 clinical isolates of A. baumannii [Zone diameter (mm) and MIC (ug/mL)].

Donors	1D1	1D2	2D1	3D1		3D2		4D1		5D1	6D1	6D2	7D1	7D2	8D1	8D2	9D1	10D1
Recipients	1R1	1R2	2R1	3R1		3R2		4R1	4R1b	5R1	6R1	6R2	7R1	7R2	8R1	8R2	9R1	10R1
Isolate type	PF	PF	PF	PF	DL	PF	DL	DL	DL	PF	PF	PF	PF	PF	PF	PF	PF	PF
Zone diameter (mm)
PP	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	19
PTC	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	22
TZ	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	19
CT	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	17
PM	6	11	6	6	6	6	6	6	6	6	6	6	10	9	6	6	6	20
IP	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	26
MP	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	24
AT	6	6	6	6	6	6	6	6	6	6	6	6	10	6	6	6	6	13
GM	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	19
AK	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	18	19
CI	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	22
MIC (mg/L)
TGC	1.5	3	1.5	2	3	3	2	2	8	3	3	3	3	3	2	2	2	0.125
PO	0.5	0.5	0.5	0.5	3	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.38	0.5

^※PP: Piperacillin, PTC: Piperacillin/Tazobactam, TZ: Ceftazidime, CT: Cefotaxime, PM: Cefepime, IP: Imipenem, MP: Meropenem, AT: Aztreonam, GM: Gentamicin, AK: Amikacin, CI: Ciprofloxacin, TGC: Tigecycline, PO: Polymyxin.

^※PF: preservation fluid, DL: draining liquid.